Clinical research and objective evaluation of TCM characteristic diagnosis and treatment system for heart failure combined with anemia

Not Applicable

• Conditions: heart failure

• Registration Number: ITMCTR2000003811
• Lead Sponsor: Shanghai municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) According to the diagnostic standard of Western medicine for heart failure;
(2) NYHA class II-III cardiac function;
(3) Aged 18-70 years old, male and female;
(4) Those who voluntarily participated in the trial and signed the informed consent.

Exclusion Criteria

(1) Late HF, moderate to severe aortic stenosis;
(2) Uncontrolled arterial hypertension;
(3) Patients with acute or chronic infection, advanced liver disease, end-stage chronic kidney disease or malignant disease;
(4) Patients with oral iron (> 100mg / day), intravenous iron or erythropoietin, and non HF related anemia (such as hemoglobinopathy) in the past 6 weeks;
(5) Patients with active bleeding or requiring blood transfusion and patients with known iron overload;
(6) Participants in other drug trials within three months before screening;
(7) According to the judgment of the researcher, it is not suitable for the participants.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin-1;NT-proBNP;C-reactive protein;Interleukin-6;Hemoglobin;Serum ferritin;C-reactive protein;Transferrin saturation;

Secondary Outcome Measures

Name	Time	Method
bilirubin;creatinine;